TNDM (STOCKS)
Tandem Diabetes Care, Inc.
$18.690000
-0.970000 (-4.93%)
Prev close: $19.660000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- John F. Sheridan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,266.55M
- Employees
- 2,650
- P/E (TTM)
- -6.45
- P/B (TTM)
- 10.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
15
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.31 | $-0.32 | +0.0102 | +3.19% |
|
Jun 2025 (Q2)
|
$-0.48 | $-0.41 | -0.0761 | -18.66% |
|
Mar 2025 (Q1)
|
$-0.66 | $-0.62 | -0.0355 | -5.68% |
|
Dec 2024 (Q4)
|
$0.01 | $-0.23 | +0.2442 | +104.27% |
Financial Statements
| Revenues | $349.45M |
| Benefits Costs and Expenses | $291.71M |
| Cost Of Revenue | $221.03M |
| Costs And Expenses | $291.93M |
| Gross Profit | $128.42M |
| Nonoperating Income/Loss | $217.00K |
| Operating Expenses | $70.89M |
| Depreciation and Amortization | $13.91M |
| Other Operating Expenses | $56.98M |
| Operating Income/Loss | $57.52M |
| Income/Loss From Continuing Operations After Tax | $36.16M |
| Income/Loss From Continuing Operations Before Tax | $57.74M |
| Income Tax Expense/Benefit | $21.57M |
| Income Tax Expense/Benefit, Deferred | $3.49M |
| Net Income/Loss | $36.16M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $36.16M |
| Net Income/Loss Available To Common Stockholders, Basic | $36.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $100.00K |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.06 |
| Diluted Earnings Per Share | $1.05 |
| Basic Average Shares | 34,212,843 |
| Diluted Average Shares | 34,421,213 |
| Assets | $238.53M |
| Current Assets | $179.43M |
| Accounts Receivable | $54.76M |
| Prepaid Expenses | $3.61M |
| Other Current Assets | $121.06M |
| Noncurrent Assets | $59.09M |
| Fixed Assets | $50.82M |
| Other Non-current Assets | $8.28M |
| Liabilities | $40.55M |
| Current Liabilities | $40.55M |
| Accounts Payable | $3.72M |
| Wages | $3.57M |
| Other Current Liabilities | $33.26M |
| Noncurrent Liabilities | $0.00 |
| Equity | $197.98M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $197.98M |
| Liabilities And Equity | $238.53M |
| Net Cash Flow From Operating Activities | $54.87M |
| Net Cash Flow From Operating Activities, Continuing | $54.87M |
| Net Cash Flow From Investing Activities | -$31.03M |
| Net Cash Flow From Investing Activities, Continuing | -$31.03M |
| Net Cash Flow From Financing Activities | -$15.45M |
| Net Cash Flow From Financing Activities, Continuing | -$15.45M |
| Net Cash Flow | $8.39M |
| Net Cash Flow, Continuing | $8.39M |
| Comprehensive Income/Loss | $36.16M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $36.16M |
| Other Comprehensive Income/Loss | $0.00 |